Tackling the difficult challenge of encouraging participation by asking this simple question and waiting for a response
https://ift.tt/2L4yaQx
Αρχειοθήκη ιστολογίου
-
▼
2023
(138)
-
▼
Φεβρουαρίου
(74)
-
▼
Φεβ 19
(9)
- Multifunctional Two-Dimensional Bi2Se3 Nanodiscs f...
- Downregulation of miR‐193a/b‐3p during HPV‐induced...
- The ability of magnetic resonance imaging to predi...
- Frequent EGFR exon 20 insertion in the so‐called p...
- Central odontogenic fibroma with amyloid: a diagno...
- Tixagevimab/Cilgavimab Treatment and Cardiovascula...
- The Ixodes ricinus salivary gland proteome during ...
- Characterization of protein-based risk signature t...
- Acute Posterior Multifocal Placoid Pigment Epithel...
-
▼
Φεβ 19
(9)
- ► Ιανουαρίου (64)
-
▼
Φεβρουαρίου
(74)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
►
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
- ► Φεβρουαρίου (793)
Αναζήτηση αυτού του ιστολογίου
Σάββατο 8 Δεκεμβρίου 2018
1 simple question to increase audience participation
Predictors of early recurrence after strictureplasty for Crohn’s disease of the small bowel during the years of biologics
The identification of patients prone to early recurrence of Crohn's disease at the site of a strictureplasty is fundamental in the clinical practice.
https://ift.tt/2G4ysHW
Changes in event-related potentials during dual task walking in aging and Parkinson's disease
It has been theorized that walking in everyday life conditions requires higher cognitive processes that utilizes a complex neural network that incorporates cognitive and motor information (Woollacott and Shumway-Cook, 2002; Yogev-Seligmann et al., 2008). Most evidence supporting this notion relies on behavioral studies stemming from dual-task paradigms during walking to increase cognitive demands. These studies show that adding a simultaneous task to walking taxes executive function and attention and leads to changes in gait performance (Hausdorff et al., 2008; Yogev-Seligmann et al., 2008).
https://ift.tt/2zMPGnW
Increased Emg Intermuscular Coherence and Reduced Signal Complexity in Parkinson’s Disease
The severity of the symptoms of Parkinson's disease (PD) are currently clinically evaluated using subjective scores such as the Movement Disorders Society Unified-Parkinson's-Disease-Rating-Scale (MDS-UPDRS) (Goetz et al., 2008). The semi-quantitative score, MDS-UPDRS III, provides a macro view of motor control without characterising specific patient kinematics. There is a recognised need for more quantitative measures to evaluate motor symptoms in PD which can provide insights into changes in neural control and provide an objective biomarker for diagnosis.
https://ift.tt/2Pr7Hgk
Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer‐specific molecule
Summary
The present state of therapy for colorectal cancer (CRC) is far from satisfactory, highlighting the need for new targets for this disease. We identified a new colorectal cancer (CRC)‐specific molecule, TMEM180, a predicted eleven‐pass transmembrane protein that apparently functions as a cation symporter. We developed the anti‐TMEM180 monoclonal antibody (mAb) and then succeeded in humanizing the mAb. Immunohistochemistry (IHC) in CRC with the mAb showed a similar positivity rate as compared with anti‐EGFR mAb and the IHC with anti‐TMEM180 mAb did not show staining in major organs used in this study. The immune‐electron microscopy clearly indicated that TMEM180 was present on the tumor exosome. The TMEM180 promoter region contains ten hypoxia‐responsive element consensus sequences; accordingly SW480 cells upregulated TMEM180 under low‐oxygen conditions. The anti‐TMEM180 mAb possessed in vitro ADCC and CDC activity, and SW480 CRC xenografts were eradicated by the mAb.
These data indicate that TMEM180 may be a new CRC marker and that a mAb against this protein could be used as antibody‐based therapeutic against CRC.
This article is protected by copyright. All rights reserved.
https://ift.tt/2BXUIiG
What information do patients want across their cancer journeys? A network analysis of cancer patients’ information needs
Most cancer patients wish to be well informed at all stages of their cancer journeys. Patients want information about their care, and receiving valued information is very strongly related to satisfaction with that care. If patients have their information needs met, especially during stages within the cancer journey when information needs are highest, they are more likely to be satisfied with their care.
Abstract
Background
Patients want information across their cancer journeys. We investigated what sort of information they want and at what stage in the cancer journey by examining English patients' satisfaction derived from ratings of their care.
Methods
Using patient experience data from 209 Clinical Commission Groups (CCGs) involving 72 788 respondents in 2016, overall patient satisfaction ratings and information needs questions were extracted. Novel network analysis techniques were used to construct an undirected weighted concentration network to assess the relationship between information needs and patient satisfaction.
Results
From the network analysis, we found that patients value information early in the pathway; there were higher associations between patient satisfaction and when information needs are met in earlier phases of the cancer journey. Across the stages of the cancer journey, strong associations between information needs and patient satisfaction emerged during diagnostic testing and also at those points when patients received information provided by the clinical nurse specialists. A mixture of strong and weak associations between patient satisfaction and information needs was found during later phases of the cancer journey, specifically when patients move from treatment to home care. Our study identified that meeting needs for information related to supportive care may be a weaker factor in patient satisfaction than meeting needs for information related to the patient's disease, its treatment and the side effects of treatment.
Conclusion
If patients have their information needs met, especially during stages within the cancer journey when information needs are highest, they are more likely to be satisfied with their care. Our study has implications for information giving and improving patient satisfaction in cancer care.
https://ift.tt/2ElSQmb
-
Pharmaceutics Pharmaceutics, Vol. 12, Pages 832: Optimized Birch Bark Extract-Loaded Colloidal Dispersion Using Hydrogenated Phospholipid...
-
Vaccines Vaccines, Vol. 8, Pages 492: Anti-Flavivirus Vaccines: Review of the Present Situation and Perspectives of Subunit Vaccines Prod...
-
Cells Cells, Vol. 9, Pages 2002: Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular Carcinoma Cells, Vol. 9, Pages...